申请人:——
公开号:US20040132746A1
公开(公告)日:2004-07-08
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
本发明涉及2-取代的4-杂环芳基嘧啶、它们的制备、含有它们的药物组合物以及它们作为细胞周期依赖性激酶(CDKs)抑制剂的用途,因此可用于治疗增殖性疾病,如癌症、白血病、牛皮癣等。